Compare BGS & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BGS | SIGA |
|---|---|---|
| Founded | 1996 | 1995 |
| Country | United States | United States |
| Employees | 86 | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.5M | 401.0M |
| IPO Year | 2004 | 2016 |
| Metric | BGS | SIGA |
|---|---|---|
| Price | $5.56 | $4.57 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.70 | N/A |
| AVG Volume (30 Days) | ★ 1.8M | 869.4K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 14.02% | 13.45% |
| EPS Growth | ★ 83.02 | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | ★ $1,828,687,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.82 | $224.81 |
| P/E Ratio | ★ N/A | $13.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.67 | $4.29 |
| 52 Week High | $7.24 | $9.62 |
| Indicator | BGS | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 63.75 | 36.10 |
| Support Level | $4.85 | N/A |
| Resistance Level | $6.38 | $6.98 |
| Average True Range (ATR) | 0.21 | 0.19 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 95.35 | 26.32 |
B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.